This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series

Cecile Geuijen, PhD
Vice President, Oncology at Merus


Cecile Geuijen joined Merus in 2009 and holds a Ph.D. in Biology from the University of Utrecht. Before joining Merus she worked on the identification of new therapeutic targets in oncology at Crucell and evaluated new therapeutic targets in oncology at Genmab. She is responsible for the functional screenings of large Biclonics® antibody panels at Merus. She serves as project leader of several (pre) clinical bispecific candidate combinations including the pre-clinical work of MCLA-128 and MCLA-145 with a focus on mechanism of action studies.